Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Gonen

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The New England Journal of Medicine|November 9, 2022
Six-Month Follow-up after a Fourth BNT162b2 Vaccine DoseMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Nature Communications|March 23, 2023
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Viruses|January 21, 2023
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Michal Mandelboim, et al.
JAMA Network Open|May 23, 2023
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in IsraelMayan Gilboa, Tal Gonen, Noam Barda, et al.
The New England Journal of Medicine|March 17, 2022
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against OmicronGili Regev-Yochay, Tal Gonen, Mayan Gilboa, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The New England Journal of Medicine|November 9, 2022
Six-Month Follow-up after a Fourth BNT162b2 Vaccine DoseMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Nature Immunology|May 9, 2022
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine doseYaniv Lustig, Tal Gonen, Lilac Meltzer, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Nature Communications|March 23, 2023
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Viruses|January 21, 2023
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Michal Mandelboim, et al.
JAMA Network Open|May 23, 2023
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in IsraelMayan Gilboa, Tal Gonen, Noam Barda, et al.
The New England Journal of Medicine|March 17, 2022
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against OmicronGili Regev-Yochay, Tal Gonen, Mayan Gilboa, et al.
Pageof 5